$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Statins Market to 2018 – Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead t.....
Published: Jan-2013
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Generics in Cardiovascular Disorders Therapeutics Market to 2018 - Loss of Lipitor Market Exclusivities and .....
Published: May-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Anti-Hypertensives Market to 2017 – Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Ata.....
Published: Mar-2012
|
$3,500.00
GBI Research, a leading business intelligence provider, has released its latest research, “The Future of the Anti-Hypertensives Market – Fixed Dose Combinations with Better Dosing Convenience will Aid.....
Published: Dec-2010
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Pro.....
Published: Dec-2009
|